Sanofi (SNY)
SNYNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$48.20
-0.4900 (-1.01%) today
Closed, Nov 12, 4:00 PM ET
- Market cap
- $118.19bn
- P/E
- 9.2
- EPS, last 4 quarters
- $5.24
- Dividend yield
- 5.00%
- Day range
- –
- 52-week range
- $39.07 to $52.68
- Average volume
- –
- Previous close
- $48.69
Analysts
1 coveringHold0 buy, 1 hold, 0 sell
Targets a year out average $59.50, +23.4% from here
Earnings
next estimate $0.9400Next report
Dec 2025
+6.0%
Mar 2026
+3.8%
Jun 2026
+10.0%
Sep 2026
+25.1%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Can Moderna's First Cancer Therapy Win FDA Approval in 2027?Zacks · 3 days ago
- NVAX Stock Falls 8% Despite Q3 Earnings & Sales Beat, Costs DeclineZacks · 6 days ago
- Nurix Shares Fall 40% After Sanofi Discontinues STAT6 Degrader Program RTTNews · Nov 4, 2026
- Recursion's Q3 Earnings Beat Estimates on Sanofi Milestone RevenuesZacks · Nov 3, 2026
- Sanofi (SNY) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 2, 2026
- Sanofi Q3 Earnings Call HighlightsMarketBeat · Oct 30, 2026
- Sanofi Q3 Earnings & Sales Beat, 2026 View Up, Shares RiseZacks · Oct 30, 2026
- Sanofi Q3 Profit Climbs On Dupixent Growth; Raises FY26 Guidance; Stock Up RTTNews · Oct 30, 2026
The company
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Sanofi is the largest biopharma manufacturer in Canada, and is investing, innovating and operating across the full life sciences value chain. We are 2,000+ employees strong, invest 20% of our revenue annually in biopharma research, and are on track to deliver over $2 billion in new infrastructure investments by 2028. Sanofi is committed to our community and is working with partners to foster a long-term sustainable ecosystem and build a healthier Canada.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- Europe
- Website
- sanofi.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.